August 25, 2026 08:36 am (IST)
Follow us:
Migraine treatment injection from Dr Reddy's Lab now available in the US
Hyderabad/Princeton-NJ, Apr 19 (IBNS) Promius Pharma LLC, a subsidiary of Dr. Reddy's Laboratories Ltd, has informed on Tuesday that its ZEMBRACE SymTouch (sumatriptan injection) 3 mg, which was approved by the FDA in January 2016 for the acute treatment of migraine with or without aura in adults, is now commercially available in the U.S.
The company said that ZEMBRACE SymTouch is a pre filled, low-dose, ready-to-use, 2-step autoinjector containing 3 mg of sumatriptan, a selective 5-HT1B/ID receptor agonist. Because ZEMBRACE SymTouch is a subcutaneous injection, it may lead to rapid relief of migraine.
Migraineurs often have more than one kind of attack. Different types of medications can be used to treat different types of attacks.
According to Roger Cady, MD, Associate Executive Chairman of the National Headache Foundation “ZEMBRACE SymTouch is a welcome addition to the toolkit for acute treatment of migraine. This 3-mg, easy to-use subcutaneous injection of sumatriptan may be desired by many migraine patients who need a medication that can rapidly treat migraine attacks. Also, the 3-mg dose allows for up to 4 doses of ZEMBRACE SymTouch in a 24-hour period, thus allowing dosing flexibility for patients.”
ZEMBRACE SymTouch is available as a box of 4 autoinjectors.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Tata Power Renewables marks a major milestone with the commissioning of 190.5 MW FDRE project in Rajasthan. All details inside
Mon, Aug 24 2026
Samsung's big AI push in India: New Pune facility to power next-gen data centre cooling
Mon, Aug 24 2026
Best Indicators For Futures Trading
Mon, Aug 24 2026
China orders massive EV recall: Nearly 3 million Teslas among 4.3 million vehicles affected
Mon, Aug 24 2026
Yes Bank launches ‘YES Essence’ for women. How can you avail it?
Fri, Aug 21 2026
Aditya Birla Capital enters gold loans: What consumers should know
Fri, Aug 21 2026